• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于高效生长鲑鱼病原体鲑鱼鱼立克次体的新型液体培养基和培养条件的优化。

A novel liquid medium for the efficient growth of the salmonid pathogen Piscirickettsia salmonis and optimization of culture conditions.

机构信息

Escuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.

出版信息

PLoS One. 2013 Sep 5;8(9):e71830. doi: 10.1371/journal.pone.0071830. eCollection 2013.

DOI:10.1371/journal.pone.0071830
PMID:24039723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3764132/
Abstract

Piscirickettsia salmonis is the bacterium that causes Piscirickettsiosis, a systemic disease of salmonid fish responsible for significant economic losses within the aquaculture industry worldwide. The growth of the bacterium for vaccine formulation has been traditionally accomplished by infecting eukaryotic cell lines, a process that involves high production costs and is time-consuming. Recent research has demonstrated that it is possible to culture pure P. salmonis in a blood containing (cell-free) medium. In the present work we demonstrate the growth of P. salmonis in a liquid medium free from blood and serum components, thus establishing a novel and simplified bacteriological medium. Additionally, the new media reported provides improved growth conditions for P. salmonis, where biomass concentrations of approximately 800 mg cell dry weight L(-1) were obtained, about eight times higher than those reported for the blood containing medium. A 2- level full factorial design was employed to evaluate the significance of the main medium components on cell growth and an optimal temperature range of 23-27°C was determined for the microorganism to grow in the novel liquid media. Therefore, these results represent a breakthrough regarding P. salmonis research in order to optimize pure P. salmonis growth in liquid blood and serum free medium.

摘要

鲑鱼鱼立克次氏体是引起鱼立克次体病的细菌,这种全身性疾病会给世界范围内的水产养殖业造成重大经济损失。传统上,为了疫苗的配方,细菌的生长是通过感染真核细胞系来完成的,这个过程涉及到高昂的生产成本和耗时。最近的研究表明,在含有(无细胞)血液的培养基中培养纯鲑鱼鱼立克次体是可行的。在本工作中,我们证明了在无血液和血清成分的液体培养基中鲑鱼鱼立克次体的生长,从而建立了一种新型的简化细菌培养基。此外,所报道的新培养基为鲑鱼鱼立克次体提供了更好的生长条件,获得了约 800mg 细胞干重/L 的生物量浓度,比含血液培养基报道的生物量浓度高约 8 倍。采用 2 水平完全析因设计来评估主要培养基成分对细胞生长的重要性,并确定了该微生物在新型液体培养基中生长的最佳温度范围为 23-27°C。因此,这些结果代表了鲑鱼鱼立克次体研究的一个突破,以便优化在无血液和血清的液体培养基中纯鲑鱼鱼立克次体的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/c0c61506fc58/pone.0071830.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/a8b5349e8554/pone.0071830.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/0c0ee6f22862/pone.0071830.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/c0c61506fc58/pone.0071830.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/a8b5349e8554/pone.0071830.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/0c0ee6f22862/pone.0071830.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4621/3764132/c0c61506fc58/pone.0071830.g003.jpg

相似文献

1
A novel liquid medium for the efficient growth of the salmonid pathogen Piscirickettsia salmonis and optimization of culture conditions.一种用于高效生长鲑鱼病原体鲑鱼鱼立克次体的新型液体培养基和培养条件的优化。
PLoS One. 2013 Sep 5;8(9):e71830. doi: 10.1371/journal.pone.0071830. eCollection 2013.
2
Culture of Piscirickettsia salmonis on enriched blood agar.在强化血琼脂上培养鲑鱼立克次氏体。
J Vet Diagn Invest. 2008 Mar;20(2):213-4. doi: 10.1177/104063870802000211.
3
Growth characteristics of the intracellular pathogen, Piscirickettsia salmonis, in tissue culture and cell-free media.细胞内病原体鲑鱼立克次氏体在组织培养和无细胞培养基中的生长特性。
J Fish Dis. 2017 Aug;40(8):1115-1127. doi: 10.1111/jfd.12578. Epub 2016 Dec 27.
4
Two novel blood-free solid media for the culture of the salmonid pathogen Piscirickettsia salmonis.两种用于鲑科鱼类病原体鲑鱼立克次氏体培养的新型无血固体培养基。
J Fish Dis. 2013 Jun;36(6):587-91. doi: 10.1111/jfd.12034. Epub 2012 Nov 23.
5
Assessing the impacts of skin mucus from Salmo salar and Oncorhynchus mykiss on the growth and in vitro infectivity of the fish pathogen Piscirickettsia salmonis.评估三文鱼和虹鳟皮肤黏液对鱼类病原体鲑鱼传染性造血器官坏死病毒的生长和体外感染力的影响。
J Fish Dis. 2021 Feb;44(2):181-190. doi: 10.1111/jfd.13275. Epub 2020 Oct 2.
6
Effectiveness of egg yolk immunoglobulin against the intracellular salmonid pathogen Piscirickettsia salmonis.蛋黄免疫球蛋白对鲑鱼细胞内病原体鲑鱼立克次氏体的有效性。
J Appl Microbiol. 2015 Aug;119(2):365-76. doi: 10.1111/jam.12857. Epub 2015 Jun 25.
7
Evidence of exotoxin secretion of Piscirickettsia salmonis, the causative agent of piscirickettsiosis.鱼类传染性造血器官坏死病病原体鲑鱼弧菌的外毒素分泌证据。
J Fish Dis. 2013 Aug;36(8):703-9. doi: 10.1111/jfd.12019. Epub 2013 Jan 24.
8
Complete genome sequence of Piscirickettsia salmonis LF-89 (ATCC VR-1361) a major pathogen of farmed salmonid fish.养殖鲑科鱼类的主要病原体——鲑立克次氏体LF-89(ATCC VR-1361)的全基因组序列
J Biotechnol. 2015 Oct 20;212:30-1. doi: 10.1016/j.jbiotec.2015.07.017. Epub 2015 Jul 26.
9
Piscirickettsiosis and Piscirickettsia salmonis in fish: a review.鱼类中的传染性造血器官坏死病和鲑鱼传染性造血器官坏死病:综述。
J Fish Dis. 2014 Mar;37(3):163-88. doi: 10.1111/jfd.12211. Epub 2013 Nov 26.
10
Vaccines for piscirickettsiosis (salmonid rickettsial septicaemia, SRS): the Chile perspective.鱼类立克次氏体病(鲑鱼立克次氏体败血症,SRS)疫苗:智利视角。
Expert Rev Vaccines. 2017 Mar;16(3):215-228. doi: 10.1080/14760584.2017.1244483. Epub 2016 Oct 12.

引用本文的文献

1
Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy against .用于氟苯尼考递送的鲑鱼免疫球蛋白M功能化聚乳酸-羟基乙酸共聚物纳米系统作为一种抗……的抗菌策略
Nanomaterials (Basel). 2024 Oct 16;14(20):1658. doi: 10.3390/nano14201658.
2
Blends of Organic Acids Are Weaponizing the Host iNOS and Nitric Oxide to Reduce Infection of in vitro.有机酸混合物正在利用宿主诱导型一氧化氮合酶和一氧化氮来减少体外感染。
Antioxidants (Basel). 2024 Apr 28;13(5):542. doi: 10.3390/antiox13050542.
3
KLF17 is an important regulatory component of the transcriptomic response of Atlantic salmon macrophages to infection.

本文引用的文献

1
Biofilm generation by Piscirickettsia salmonis under growth stress conditions: a putative in vivo survival/persistence strategy in marine environments.鲑鱼弧菌在生长胁迫条件下生成生物膜:海洋环境中一种潜在的体内生存/持久策略。
Res Microbiol. 2012 Sep-Oct;163(8):557-66. doi: 10.1016/j.resmic.2012.08.002. Epub 2012 Aug 4.
2
Broth medium for the successful culture of the fish pathogen Piscirickettsia salmonis .用于鱼类病原体鲑鱼立克次氏体成功培养的肉汤培养基。
Dis Aquat Organ. 2012 Jan 24;97(3):197-205. doi: 10.3354/dao02403.
3
Oral vaccination of Atlantic salmon (Salmo salar) against salmonid rickettsial septicaemia.
KLF17 是大西洋鲑鱼巨噬细胞对 感染转录组反应的重要调节组成部分。
Front Immunol. 2023 Dec 14;14:1264599. doi: 10.3389/fimmu.2023.1264599. eCollection 2023.
4
Ongoing diversification of the global fish pathogen Piscirickettsia salmonis through genetic isolation and transposition bursts.全球鱼类病原体鲑鱼鱼立克次氏体通过遗传隔离和转座爆发不断多样化。
ISME J. 2023 Dec;17(12):2247-2258. doi: 10.1038/s41396-023-01531-9. Epub 2023 Oct 18.
5
RNA-Seq-Based Analysis of Cortisol-Induced Differential Gene Expression Associated with Infection in Rainbow Trout () Myotubes.基于RNA测序的虹鳟鱼肌管中与感染相关的皮质醇诱导差异基因表达分析
Animals (Basel). 2021 Aug 13;11(8):2399. doi: 10.3390/ani11082399.
6
The Phagosome-Lysosome Fusion Is the Target of a Purified Extract (PQSE) in Reducing Infection of Fish Macrophages by the Bacterial Pathogen .吞噬体-溶酶体融合是一种纯化提取物(PQSE)减少细菌病原体对鱼类巨噬细胞感染的作用靶点。
Antibiotics (Basel). 2021 Jul 12;10(7):847. doi: 10.3390/antibiotics10070847.
7
Piscirickettsia salmonis shedding and tissue burden, and hematological responses during cohabitation infections in chum Oncorhynchus keta, pink O. gorbuscha and Atlantic salmon Salmo salar.鲑鱼鱼虱病在养殖的大麻哈鱼、红大麻哈鱼和大西洋鲑鱼中的共感染期间的排菌和组织负荷以及血液学反应。
PLoS One. 2021 Mar 5;16(3):e0248098. doi: 10.1371/journal.pone.0248098. eCollection 2021.
8
Non-Specific Antibodies Induce Lysosomal Activation in Atlantic Salmon Macrophages Infected by .非特异性抗体诱导大西洋鲑鱼巨噬细胞中. 感染后的溶酶体激活
Front Immunol. 2020 Nov 12;11:544718. doi: 10.3389/fimmu.2020.544718. eCollection 2020.
9
Pharmacological iron-chelation as an assisted nutritional immunity strategy against Piscirickettsia salmonis infection.药理学铁螯合作为一种辅助营养免疫策略,用于对抗鲑鱼弧菌感染。
Vet Res. 2020 Oct 28;51(1):134. doi: 10.1186/s13567-020-00845-2.
10
Development of a Piscirickettsia salmonis immersion challenge model to investigate the comparative susceptibility of three salmon species.建立鲑鱼鱼虱气单胞菌浸泡感染模型以研究三种鲑鱼品种的相对易感性
J Fish Dis. 2021 Jan;44(1):1-9. doi: 10.1111/jfd.13261. Epub 2020 Oct 16.
口服疫苗接种大西洋鲑(Salmo salar)防治鲑鱼立克次体败血症。
Vaccine. 2011 Mar 9;29(12):2336-40. doi: 10.1016/j.vaccine.2010.12.107. Epub 2011 Jan 8.
4
Productive infection of Piscirickettsia salmonis in macrophages and monocyte-like cells from rainbow trout, a possible survival strategy.鲑鱼立克次氏体在虹鳟巨噬细胞和单核细胞样细胞中的有效感染:一种可能的生存策略
J Cell Biochem. 2009 Oct 15;108(3):631-7. doi: 10.1002/jcb.22295.
5
Culture of Piscirickettsia salmonis on enriched blood agar.在强化血琼脂上培养鲑鱼立克次氏体。
J Vet Diagn Invest. 2008 Mar;20(2):213-4. doi: 10.1177/104063870802000211.
6
Characterization of a novel and genetically different small infective variant of Piscirickettsia salmonis.一种新型且基因不同的鲑鱼立克次氏体小感染性变体的特性分析。
Microb Pathog. 2008 May;44(5):370-8. doi: 10.1016/j.micpath.2007.10.012. Epub 2007 Nov 5.
7
Agar culture of Piscirickettsia salmonis, a serious pathogen of farmed salmonid and marine fish.鲑鱼立克次氏体的琼脂培养,鲑鱼立克次氏体是养殖鲑科鱼类和海鱼的一种严重病原体。
FEMS Microbiol Lett. 2008 Jan;278(1):43-7. doi: 10.1111/j.1574-6968.2007.00977.x. Epub 2007 Nov 19.
8
Cysteine metabolism in Legionella pneumophila: characterization of an L-cystine-utilizing mutant.嗜肺军团菌中的半胱氨酸代谢:一株利用L-胱氨酸的突变体的特性
Appl Environ Microbiol. 2006 Jun;72(6):3993-4000. doi: 10.1128/AEM.00684-06.
9
Genetic characterization and experimental pathogenesis of Piscirickettsia salmonis isolated from white seabass Atractoscion nobilis.从白鲈(Atractoscion nobilis)分离出的鲑鱼立克次氏体的遗传特征及实验致病性
Dis Aquat Organ. 2005 Feb 28;63(2-3):139-49. doi: 10.3354/dao063139.
10
Growth of Piscirickettsia salmonis to high titers in insect tissue culture cells.鲑鱼立克次氏体在昆虫组织培养细胞中生长至高滴度。
Infect Immun. 2004 Jun;72(6):3693-4. doi: 10.1128/IAI.72.6.3693-3694.2004.